Previous 10 | Next 10 |
Adagene, a Suzhou immunotherapy company, plans to raise up to $125 million in a US IPO on the NASDAQ Exchange. TenNor Therapeutics (Suzhou), a company that develops dual-action antibiotics, announced a research collaboration with Janssen Pharma that will use TenNor's drug conjugation ...
Brazil’s health regulator Anvisa has approved the COVID-19 vaccines developed by AstraZeneca (AZN) and Sinovac Biotech (SVA) for emergency use, clearing the way for the nation with the second-highest COVID-19 death toll to start the government-led vaccine rollo...
J&J has published a bit more on their trials of their adenovirus-vector candidate, with data on the immunogenicity of the vaccine in patients. The New York Times reported yesterday that J&J has told the US government that they might have fallen as much as two months behind on ...
Indonesian President Joko Widodo received the first shot of a China's Sinovac Biotech's (SVA) COVID-19 vaccine, CoronaVac after Indonesia approved it for emergency use.The vaccine was cleared for emergency use based on clinical trial data and after the Indonesian Ulema Council declared the va...
The Philippines will sign a deal with AstraZeneca (AZN) on Thursday for up to 20M additional doses of its COVID-19 vaccines, source Bloomberg.The first shipments of the vaccine are expected to arrive this quarter, said vaccine czar Carlito Galvez.Vaccines from Pfizer will be obtained through ...
On Wednesday, China's National Medical Products Administration granted the conditional marketing approval for the COVID-19 vaccine candidate developed by Beijing Biological Products Institute and Sinopharm Group (SHTDF).Based mainly on trials conducted in the United Arab Emirates, t...
The UK authorities have approved Oxford/AstraZeneca’s adenovirus vector vaccine for distribution there. Of special interest is the intent to give as many people as possible a first shot, without holding back supplies for the second round. This is simultaneously the correct decision...
BEIJING and BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) -- 1Globe Capital LLC (“1GlobeCap”), a principal and long-term shareholder of Sinovac Biotech (NASDAQ: SVA) (“Sinovac”), has reached agreement with the Securities and Exchange Commission (“SEC”) to ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. iCar?Apple's (AAPL) Project Titan is not only alive, but plans to produce an electric passenger vehicle with "breakthrough battery technology" and self-dri...
Sinovac Biotech's (SVA) coronavirus vaccine has passed the 50% threshold for efficacy in late-stage trials in Brazil, WSJ reports.Considering these results, regulators can give it the green light for use, said people involved in its development.Brazil is the first country to complete Phase 3 ...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- LONDON, Ontario; BOSTON, Massachusetts – TheNewswire – May 1, 2024, Sernova Corp. (“Sernova” or the “Corporation”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) a clinical-stage biotechnology company focused on the development of regenerativ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023. The annual r...
--News Direct-- Dr. Philip Toleikis to retire as of April 30, 2024 Cost savings from restructuring and strategic transformation anticipated to extend runway Board rebuild underway LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - April 25, 2024 –...